JP2024519819A5 - - Google Patents

Info

Publication number
JP2024519819A5
JP2024519819A5 JP2023571323A JP2023571323A JP2024519819A5 JP 2024519819 A5 JP2024519819 A5 JP 2024519819A5 JP 2023571323 A JP2023571323 A JP 2023571323A JP 2023571323 A JP2023571323 A JP 2023571323A JP 2024519819 A5 JP2024519819 A5 JP 2024519819A5
Authority
JP
Japan
Prior art keywords
composition
aav
use according
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023571323A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519819A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/029797 external-priority patent/WO2022245919A1/en
Publication of JP2024519819A publication Critical patent/JP2024519819A/ja
Publication of JP2024519819A5 publication Critical patent/JP2024519819A5/ja
Pending legal-status Critical Current

Links

JP2023571323A 2021-05-18 2022-05-18 眼疾患および障害を処置するための方法および組成物 Pending JP2024519819A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163189836P 2021-05-18 2021-05-18
US63/189,836 2021-05-18
US202163275527P 2021-11-04 2021-11-04
US63/275,527 2021-11-04
US202263334949P 2022-04-26 2022-04-26
US63/334,949 2022-04-26
PCT/US2022/029797 WO2022245919A1 (en) 2021-05-18 2022-05-18 Methods and compositions for treating ocular diseases and disorders

Publications (2)

Publication Number Publication Date
JP2024519819A JP2024519819A (ja) 2024-05-21
JP2024519819A5 true JP2024519819A5 (cg-RX-API-DMAC7.html) 2025-05-26

Family

ID=84140790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023571323A Pending JP2024519819A (ja) 2021-05-18 2022-05-18 眼疾患および障害を処置するための方法および組成物

Country Status (5)

Country Link
US (1) US20240269326A1 (cg-RX-API-DMAC7.html)
EP (1) EP4340856A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024519819A (cg-RX-API-DMAC7.html)
CA (1) CA3216533A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022245919A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112021009913A2 (pt) 2018-12-05 2021-08-17 Abeona Therapeutics, Inc. vetor viral adeno-associado recombinante para inserção gênica
AU2024294136A1 (en) * 2023-07-20 2026-02-05 Children's Medical Research Institute Modified cardiotropic aav capsid polypeptides and vectors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3012344A1 (en) * 2016-02-12 2017-08-17 University Of Massachusetts Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
WO2020018766A1 (en) * 2018-07-20 2020-01-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Intraocular delivery of gene therapy expression vectors
BR112021009913A2 (pt) * 2018-12-05 2021-08-17 Abeona Therapeutics, Inc. vetor viral adeno-associado recombinante para inserção gênica

Similar Documents

Publication Publication Date Title
US20220387560A1 (en) Adeno-Associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease
JP2022515338A5 (cg-RX-API-DMAC7.html)
WO2023284879A1 (en) Modified aav capsid for gene therapy and methods thereof
CN111819281B (zh) 用于神经变性疾病的基因疗法
EP2661494B1 (en) Promoters, expression cassettes and vectors for use treating achromatopsia and other diseases
JP2024519888A5 (cg-RX-API-DMAC7.html)
JP2022531861A5 (cg-RX-API-DMAC7.html)
JP2023535956A5 (cg-RX-API-DMAC7.html)
JP2022516317A5 (cg-RX-API-DMAC7.html)
US20250213722A1 (en) Adeno-associated virus vectors for nucleic acid delivery to retinal ganglion cells and/or retinal pigment epithelium cells
AU2017222948B2 (en) Gene therapy for the treatment of a disease of retinal cone cells
AU2017222231B2 (en) Gene therapy for the treatment of a retinal degeneration disease
US20250327092A1 (en) Adeno-associated virus vectors for nucleic acid delivery to retinal cells
JP2025503910A5 (cg-RX-API-DMAC7.html)
JP2024519819A (ja) 眼疾患および障害を処置するための方法および組成物
JP2023551254A5 (cg-RX-API-DMAC7.html)
US20250222135A1 (en) Adeno-associated virus vectors for nucleic acid delivery across retinal regions
JP2022523050A5 (cg-RX-API-DMAC7.html)
CN113347962A (zh) 通过合理设计增强的新型aav病毒在视网膜中的高效转导和侧向扩散
US20260042803A1 (en) Variant aav capsid polypeptides targeting the eye
TW202615665A (zh) 腺相關病毒載體
WO2026039585A2 (en) Adeno-associated virus vectors
WO2025231336A1 (en) Adeno-associated virus vectors
WO2024110770A1 (en) A new promoter for retinal pigment epithelium (rpe) targeted gene therapy
WO2025072698A2 (en) Aav9 vectors and capsid polypeptides for use in treating cns disorders